HormonesHormone Therapy Linked to More Frequent, Longer Migraines in Postmenopausal Women
Migraine and menopausal hormone therapy are the focus of a new systematic review and meta-analysis to be presented at the 2026 Menopause Society meeting. Researchers pooled five studies covering nearly 24,000 postmenopausal women, with an average migraine incidence of about 19%. Women using hormone therapy had more frequent migraine attacks and longer-lasting episodes. However, they did not differ in migraine severity scores or in how many analgesics they used each month. The authors call for further clinical trials to clarify the underlying physiology. The Menopause Society's medical director cautions against reading the result as cause and effect. Women with migraine may be more likely to seek treatment for menopause symptoms, so the findings may reflect differences between women who choose hormone therapy and those who do not. She notes that hormone therapy remains the most effective treatment for bothersome hot flashes and night sweats, and can be used safely in many women with migraine. Decisions should be individualized.